XML 174 R162.htm IDEA: XBRL DOCUMENT v3.20.2
Supplementary Information - Condensed Consolidating Financial Information Cash Flow (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash Flows From Operating Activities      
Net Cash Provided by (Used in) Operating Activities $ 11,104 $ 12,934 $ 7,077
Cash Flows From Investing Activities      
Capital expenditures and investments (6,636) (6,750) (4,591)
Increase (Decrease) In Capital Accrual Associated With Investing Activities (103) (68) 132
Proceeds from asset dispositions 3,012 1,082 13,860
Net Sales (Purchases) of Investments (2,910) 1,620 (1,790)
Long-term advances/loans-related parties 0 0 0
Collection of advances/loans-related parties 127 119 115
Intercompany Cash Management 0 0 0
Other (108) 154 36
Net Cash Provided by (Used in) Investing Activities (6,618) (3,843) 7,762
Cash Flows From Financing Activities      
Issuance of debt 0 0 0
Repayment of debt (80) (4,995) (7,876)
Issuance of company common stock (30) 121 (63)
Repurchase of company common stock (3,500) (2,999) (3,000)
Dividends paid (1,500) (1,363) (1,305)
Other (119) (123) (112)
Net Cash Provided by (Used in) Financing Activities (5,229) (9,359) (12,356)
Effect of Exchange Rate Changes on Cash and Cash Equivalents and Restricted Cash (46) (117) 232
Net Change in Cash and Cash Equivalents and Restricted Cash (789) (385) 2,715
Cash and Cash Equivalents and Restricted Cash at beginning of period 6,151 [1] 6,325 [1] 3,610
Cash and Cash Equivalents and Restricted Cash at end of period [1] 5,362 6,151 6,325
Restatement Adjustment [Member]      
Cash Flows From Financing Activities      
Cash and Cash Equivalents and Restricted Cash at beginning of period   6,536  
Cash and Cash Equivalents and Restricted Cash at end of period     6,536
ConocoPhillips [Member]      
Cash Flows From Operating Activities      
Net Cash Provided by (Used in) Operating Activities 1,457 860 71
Cash Flows From Investing Activities      
Capital expenditures and investments   0 0
Increase (Decrease) In Capital Accrual Associated With Investing Activities   0 0
Proceeds from asset dispositions 2,374 3,457 7,765
Net Sales (Purchases) of Investments 0 0 0
Long-term advances/loans-related parties 0 0 0
Collection of advances/loans-related parties 0 589 658
Intercompany Cash Management 1,060 (803) 1,151
Other 0 0 0
Net Cash Provided by (Used in) Investing Activities 3,434 3,243 9,574
Cash Flows From Financing Activities      
Issuance of debt 0 0 0
Repayment of debt 0 0 (5,459)
Issuance of company common stock 105 254 115
Repurchase of company common stock (3,500) (2,999) (3,000)
Dividends paid (1,500) (1,363) (1,305)
Other 4 5 4
Net Cash Provided by (Used in) Financing Activities (4,891) (4,103) (9,645)
Effect of Exchange Rate Changes on Cash and Cash Equivalents and Restricted Cash 0 0 0
Net Change in Cash and Cash Equivalents and Restricted Cash 0 0 0
Cash and Cash Equivalents and Restricted Cash at beginning of period 0 0 0
Cash and Cash Equivalents and Restricted Cash at end of period 0 0 0
ConocoPhillips [Member] | Restatement Adjustment [Member]      
Cash Flows From Financing Activities      
Cash and Cash Equivalents and Restricted Cash at beginning of period 0    
Cash and Cash Equivalents and Restricted Cash at end of period   0  
ConocoPhillips Company [Member]      
Cash Flows From Investing Activities      
Collection of advances/loans-related parties     200
Reportable Legal Entities [Member] | ConocoPhillips [Member]      
Cash Flows From Investing Activities      
Capital expenditures and investments 0    
Increase (Decrease) In Capital Accrual Associated With Investing Activities 0    
Reportable Legal Entities [Member] | ConocoPhillips Company [Member]      
Cash Flows From Operating Activities      
Net Cash Provided by (Used in) Operating Activities 7,986 4,019 1,183
Cash Flows From Investing Activities      
Capital expenditures and investments (2,517) (980) (1,663)
Increase (Decrease) In Capital Accrual Associated With Investing Activities 37 (110) 194
Proceeds from asset dispositions 7,047 666 11,146
Net Sales (Purchases) of Investments (2,803) 0 0
Long-term advances/loans-related parties (812) (126) (214)
Collection of advances/loans-related parties 141 3,432 1,527
Intercompany Cash Management (2,849) 3,504 101
Other (149) 151 (8)
Net Cash Provided by (Used in) Investing Activities (1,905) 6,537 11,083
Cash Flows From Financing Activities      
Issuance of debt 0 10 20
Repayment of debt (21) (4,865) (4,411)
Issuance of company common stock 0 0 0
Repurchase of company common stock 0 0 0
Dividends paid (4,034) (1,043) (235)
Other 0 (3,468) (7,765)
Net Cash Provided by (Used in) Financing Activities (4,055) (9,366) (12,391)
Effect of Exchange Rate Changes on Cash and Cash Equivalents and Restricted Cash (11) 4 1
Net Change in Cash and Cash Equivalents and Restricted Cash 2,015 1,194 (124)
Cash and Cash Equivalents and Restricted Cash at beginning of period 1,428 234 358
Cash and Cash Equivalents and Restricted Cash at end of period 3,443 1,428 234
Reportable Legal Entities [Member] | ConocoPhillips Company [Member] | Restatement Adjustment [Member]      
Cash Flows From Financing Activities      
Cash and Cash Equivalents and Restricted Cash at beginning of period 1,428    
Cash and Cash Equivalents and Restricted Cash at end of period   1,428  
Reportable Legal Entities [Member] | Burlington Resources LLC [Member]      
Cash Flows From Operating Activities      
Net Cash Provided by (Used in) Operating Activities 3,207 838 2,971
Cash Flows From Investing Activities      
Capital expenditures and investments 0 (603) (4,351)
Increase (Decrease) In Capital Accrual Associated With Investing Activities 0 0 0
Proceeds from asset dispositions 769 1,926 12,178
Net Sales (Purchases) of Investments 0 0 0
Long-term advances/loans-related parties 0 (173) (65)
Collection of advances/loans-related parties 0 212 389
Intercompany Cash Management 1,402 (2,150) (1,341)
Other 0 0 0
Net Cash Provided by (Used in) Investing Activities 2,171 (788) 6,810
Cash Flows From Financing Activities      
Issuance of debt 0 0 0
Repayment of debt 0 (53) 0
Issuance of company common stock 0 0 0
Repurchase of company common stock 0 0 0
Dividends paid (454) 0 0
Other (4,924) 0 (9,781)
Net Cash Provided by (Used in) Financing Activities (5,378) (53) (9,781)
Effect of Exchange Rate Changes on Cash and Cash Equivalents and Restricted Cash 0 0 (2)
Net Change in Cash and Cash Equivalents and Restricted Cash 0 (3) (2)
Cash and Cash Equivalents and Restricted Cash at beginning of period 0 3 5
Cash and Cash Equivalents and Restricted Cash at end of period 0 0 3
Reportable Legal Entities [Member] | Burlington Resources LLC [Member] | Restatement Adjustment [Member]      
Cash Flows From Financing Activities      
Cash and Cash Equivalents and Restricted Cash at beginning of period 0    
Cash and Cash Equivalents and Restricted Cash at end of period   0  
Reportable Legal Entities [Member] | All Other Subsidiaries [Member]      
Cash Flows From Operating Activities      
Net Cash Provided by (Used in) Operating Activities 9,803 14,132 5,904
Cash Flows From Investing Activities      
Capital expenditures and investments (5,714) (5,777) (3,795)
Increase (Decrease) In Capital Accrual Associated With Investing Activities (140) 42 (62)
Proceeds from asset dispositions 1,055 705 12,796
Net Sales (Purchases) of Investments (107) 1,620 (1,790)
Long-term advances/loans-related parties 0 (10) (20)
Collection of advances/loans-related parties 147 129 2,196
Intercompany Cash Management 387 (551) 89
Other 41 3 44
Net Cash Provided by (Used in) Investing Activities (4,331) (3,839) 9,458
Cash Flows From Financing Activities      
Issuance of debt 812 299 279
Repayment of debt (220) (4,320) (2,661)
Issuance of company common stock 0 0 0
Repurchase of company common stock 0 0 0
Dividends paid (7,097) (6,057) (2,995)
Other (1,736) (1,670) (7,377)
Net Cash Provided by (Used in) Financing Activities (8,241) (11,748) (12,754)
Effect of Exchange Rate Changes on Cash and Cash Equivalents and Restricted Cash (35) (121) 233
Net Change in Cash and Cash Equivalents and Restricted Cash (2,804) (1,576) 2,841
Cash and Cash Equivalents and Restricted Cash at beginning of period 4,723 6,088 3,247
Cash and Cash Equivalents and Restricted Cash at end of period 1,919 4,723 6,088
Reportable Legal Entities [Member] | All Other Subsidiaries [Member] | Restatement Adjustment [Member]      
Cash Flows From Financing Activities      
Cash and Cash Equivalents and Restricted Cash at beginning of period 4,723 6,299  
Cash and Cash Equivalents and Restricted Cash at end of period   4,723 6,299
Consolidation, Eliminations [Member]      
Cash Flows From Operating Activities      
Net Cash Provided by (Used in) Operating Activities (11,349) (6,915) (3,052)
Cash Flows From Investing Activities      
Capital expenditures and investments 1,595 610 5,218
Increase (Decrease) In Capital Accrual Associated With Investing Activities 0 0 0
Proceeds from asset dispositions (8,233) (5,672) (30,025)
Net Sales (Purchases) of Investments 0 0 0
Long-term advances/loans-related parties 812 309 299
Collection of advances/loans-related parties (161) (4,243) (4,655)
Intercompany Cash Management 0 0 0
Other 0 0 0
Net Cash Provided by (Used in) Investing Activities (5,987) (8,996) (29,163)
Cash Flows From Financing Activities      
Issuance of debt (812) (309) (299)
Repayment of debt 161 4,243 4,655
Issuance of company common stock (135) (133) (178)
Repurchase of company common stock 0 0 0
Dividends paid 11,585 7,100 3,230
Other 6,537 5,010 24,807
Net Cash Provided by (Used in) Financing Activities 17,336 15,911 32,215
Effect of Exchange Rate Changes on Cash and Cash Equivalents and Restricted Cash 0 0 0
Net Change in Cash and Cash Equivalents and Restricted Cash 0 0 0
Cash and Cash Equivalents and Restricted Cash at beginning of period 0 0 0
Cash and Cash Equivalents and Restricted Cash at end of period 0 0 $ 0
Consolidation, Eliminations [Member] | Restatement Adjustment [Member]      
Cash Flows From Financing Activities      
Cash and Cash Equivalents and Restricted Cash at beginning of period $ 0    
Cash and Cash Equivalents and Restricted Cash at end of period   $ 0  
[1]
See Notes to Consolidated
 
Financial Statements.